ASCO: Racial disparity in HER2+ breast cancer survival subsided after trastuzumab approvalSeptember 25, 2015Breast Cancer
ASCO: Overall survival similar regardless of distant relapse site in breast cancerSeptember 25, 2015Breast Cancer
Actionable mutations are highly prevalent in young lung cancer patientsSeptember 25, 2015Lung CancerPediatrics
Meta-analysis confirms no OS benefit from antiangiogenics for NSCLC patientsSeptember 24, 2015Lung Cancer
Topical resiquimod effective for early-stage cutaneous T-cell lymphomaSeptember 24, 2015MelanomaLymphoma & Plasma Cell Disorders
More expanded drug indications approved on less rigorous evidenceSeptember 23, 2015Practice Management